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The plant microbiome represents an enormous untapped resource for discovering novel
genes and bioactive compounds. Previously, we isolated Pseudomonas sp. SH-C52
from the rhizosphere of sugar beet plants grown in a soil suppressive to the fungal
pathogen Rhizoctonia solani and showed that its antifungal activity is, in part, attributed
to the production of the chlorinated 9-amino-acid lipopeptide thanamycin (Mendes et al.,
2011). To get more insight into its biosynthetic repertoire, the genome of Pseudomonas
sp. SH-C52 was sequenced and subjected to in silico, mutational and functional
analyses. The sequencing revealed a genome size of 6.3 Mb and 5579 predicted
ORFs. Phylogenetic analysis placed strain SH-C52 within the Pseudomonas corrugata
clade. In silico analysis for secondary metabolites revealed a total of six non-ribosomal
peptide synthetase (NRPS) gene clusters, including the two previously described NRPS
clusters for thanamycin and the 2-amino acid antibacterial lipopeptide brabantamide.
Here we show that thanamycin also has activity against an array of other fungi and that
brabantamide A exhibits anti-oomycete activity and affects phospholipases of the late
blight pathogen Phytophthora infestans. Most notably, mass spectrometry led to the
discovery of a third lipopeptide, designated thanapeptin, with a 22-amino-acid peptide
moiety. Seven structural variants of thanapeptin were found with varying degrees of
activity against P. infestans. Of the remaining four NRPS clusters, one was predicted
to encode for yet another and unknown lipopeptide with a predicted peptide moiety
of 8-amino acids. Collectively, these results show an enormous metabolic potential for
Pseudomonas sp. SH-C52, with at least three structurally diverse lipopeptides, each with
a different antimicrobial activity spectrum.
Keywords: beneficial microbes, rhizosphere bacteria, antimicrobial peptides, Pseudomonads, genome
sequencing, mass spectrometry, biocontrol
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Introduction
Pseudomonas species are ubiquitous in aquatic and terrestrial
habitats, and are intensively studied for their abilities to promote
plant growth and to suppress plant pathogens (Weller, 2007;
Berendsen et al., 2012). The main mechanisms involved in plant
pathogen control are induced systemic resistance, competition,
antibiosis and parasitism (Van Loon et al., 1998; Haas andDefago,
2005; VanWees et al., 2008; Lugtenberg and Kamilova, 2009). To
date, a wide variety of bioactive compounds involved in pathogen
control have been identified for Pseudomonads (Gross and
Loper, 2009; Raaijmakers et al., 2010; Raaijmakers and Mazzola,
2012). These include siderophores, hydrogen cyanide, 2,4-
diacetylphloroglucinol, pyrrolnitrin, pyoluteorin, phenazines,
2,5-dialkylresorcinol, quinolones, gluconic acid, rhamnolipids,
and various structurally diverse lipopeptides (Gross and Loper,
2009; D’Aes et al., 2010).
Comparative genomics studies of Pseudomonas species have
shown substantial diversity between the genera, between species,
and even between strains belonging to the same species (Silby
et al., 2011; Wu et al., 2011; Loper et al., 2012; Redondo-
Nieto et al., 2012). Loper et al. (2012) further revealed that
most of the genes encoding bioactive compounds map outside
the core genome. This includes genes encoding the Non-
Ribosomal Peptide Synthetases (NRPSs). NRPSs possess a
modular structure and each module is a building block for the
stepwise incorporation of an amino acid in the peptide moiety
(Gross and Loper, 2009; Marahiel and Essen, 2009). NRPSs
are responsible for the production of an array of antimicrobial
compounds including lipopeptides (LPs). Intriguing features
of LPs are their enormous structural diversity and diverse
natural roles in microbial behavior (Raaijmakers and Mazzola,
2012). By the expansion of available genome sequences also
the number of identified NRPS gene clusters has increased
considerably over the past years. To exploit the hidden genetic
andmetabolic potential in genome sequences, a number of search
tools and approaches have been developed, including regulator-
based discovery (Hassan et al., 2010), metabolic networking,
peptidogenomics and advanced mass spectrometry methods
(Kersten et al., 2011; Watrous et al., 2012). This also led to the
discovery of NRPS gene clusters involved in the production of
structurally novel LPs (Liu et al., 2014).
Recently, we discovered Pseudomonas sp. SH-C52, a strain
representative of a larger population of Pseudomonads that
contributes to the natural suppressiveness of a soil against the
fungal plant pathogen Rhizoctonia solani (Mendes et al., 2011).
The gene cluster responsible for the activity of strain SH-
C52 against R. solani is encoded by an NRPS, predicted to
synthesize a 9-amino-acid chlorinated LP, designated thanamycin
(Mendes et al., 2011). The production and partial structure
of thanamycin was resolved by live colony mass spectrometry
(Watrous et al., 2012). Next to thanamycin, strain SH-C52 was
also found to produce a set of 2-amino-acid LPs, designated
brabantamides A-C, which contain a glycosylated 3-hydroxy fatty
acid tail. Brabantamide A displays activity against Gram-positive
bacteria, including Staphylococcus aureus and Arthrobacter
crystallopoietes (Reder-Christ et al., 2012; Schmidt et al., 2014).
The 12-kb gene cluster for brabantamide biosynthesis includes
the NRPS gene (braB), a glycosyltransferase (braA) and a
specific FAD-dependent Baeyer–Villiger monooxygenase gene
(braC). Biosynthesis of brabantamides is complex: a linear di-
peptide is formed by BraB after which the sugar moiety is
attached by the glycosyltransferase BraA. This glycosylated di-
peptide is subsequently rearranged by the brabantamide-specific
monooxygenase BraC (Schmidt et al., 2014).
To extend our knowledge on the biosynthetic repertoire of
bioactive compounds of plant-associated Pseudomonas sp. SH-
C52, we sequenced the genome and performed detailed in silico
as well as metabolomic analyses. Here we show that genome-
based phylogeny places strain SH-C52 in the Pseudomonas
corrugata subgroup of the P. fluorescens clade. Next to the
known thanamycin and brabantamide gene clusters, in silico
analysis revealed four additional NRPS gene clusters. We further
characterized the antimicrobial activity spectrum of thanamycin
and brabantamide and identified the structure, activity and gene
cluster of a novel LP with a 22-amino acid peptide moiety
designated thanapeptin.
Materials and Methods
Strains and Growth Conditions
The bacterial strains Pseudomonas sp. SH-C52 (Mendes et al.,
2011), derivatives from this strain, and Pseudomonas syringae
pv. syringae B728a were grown on Pseudomonas agar F (PSA,
Difco) or in King’s medium B (KB, King et al., 1954). Bacillus
megaterium and Pectobacterium atrosepticum SCRI1043 were
cultured on Luria Bertani (LB) agar plates or in LB broth.
When needed, growth media were supplemented with 25µg/ml
gentamycin 100µg/ml kanamycin, and/or 25µg/ml tetracycline.
All bacteria were grown at 25◦C.
Mutants in the thanapeptin gene cluster were obtained
by screening the transposon insertion mutant library of
Pseudomonas sp. SH-C52 for mutants that showed loss of or
reduced activity against R. solani (Mendes et al., 2011). The
initial screening showed the thanapeptin gene cluster mutants
(Tn-tnpA and Tn-tnpC) to have a very minor reduction in the
growth-inhibitory activity against R. solani (data not shown).
The site-directed mutants in the thanamycin gene cluster KO25
and KO26 were obtained previously and were designated in this
manuscript as dThaB and dThaC2, respectively. All fungi and
oomycetes used in this study were cultured on Potato Dextrose
Agar (PDA, Difco, Becton, Dickinson and Company, USA),
except for Phytophthora infestans strain 88069 and Phytophthora
capsici LT3239 which were cultured on Rye Sucrose Medium
and on V8 medium (Latijnhouwers et al., 2004), respectively.
P. infestans was cultured at 18◦C; whereas all other fungi and
oomycetes were cultured at 25◦C.
Illumina Genome Sequencing and Assembly
Illumina sequencing was performed by BGI (China) according
to their protocols. For this purpose, two libraries with insert
sizes of 0.5 and ∼2 kb were constructed and sequenced. In order
to ensure the accuracy of follow-up analysis, several steps were
performed to filter the raw data: removal of reads with a certain
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proportion of Ns’ bases or low complexity reads (10% as default);
removal of reads with a certain proportion of low quality (≤Q20)
bases (40 bases as default); removal of adapter contamination
(15 bp overlap between adapter and reads as default); removal of
contamination due to duplication. For reads with low sequence
quality additional processing was performed, i.e., removal of
reads with significant poly-A structure, and removal of reads
with a k-mer frequency of 1. During the processing 16% of the
original read data was eliminated. Short reads were assembled
into genomic sequences using SOAPdenovo, a BGI developed
assembler (Li et al., 2010). Using mapping information gaps were
filled and single base pairs were proofread. The usage rate of reads
was obtained according to readmapping, fromwhich the genome
coverage was estimated.
Additional Sequencing, Sequence Adjustments,
and Gene Annotation
Sequence information on the thanamycin gene cluster from
strain SH-C52 (Mendes et al., 2011) was incorporated in the
genome sequence to close gaps in the Illumina acquired assembly.
In addition, for the predicted 22 amino-acid NRPS gene cluster,
gaps were closed by additional standard Sanger sequencing
(Macrogen, Amsterdam). Specific primer pairs were designed for
PCR to cover the gaps present in the original Illumina assembly
(Table S1). Primers were used for both PCR and sequencing. PCR
products were sequenced in both orientations. Gene annotation
was performed on the complemented genome sequence by use
of RAST (http://rast.nmpdr.org) (Overbeek et al., 2014). The
genome sequence and gene annotation are available at the NCBI
and EMBL database (accession number CBLV000000000).
Genome Analysis and Comparisons
Genome comparisons were performed by use of nucleotide
BLAST (BLASTN) in BioEdit (Ibis Biosciences). Genes identified
by Loper et al. (2012) in species from the Pseudomonas
fluorescens clade were used for BLASTN analysis on the
SH-C52 genome sequence. For Pseudomonas corrugata
CFBP5454 (ATKI00000000) and Pseudomonas mandelii JR-
1 (NZ_CP005960) these analyses were performed online at the
NCBI database. In general, genes were considered to be present
when more than 65% identity with the reference sequence(s),
and more than 85% of coverage was observed. In addition to the
BLAST analysis, secretion systems were identified by screening
gene annotations.
A whole-genome phylogenetic analysis was performed with
the genomes of species of the P. fluorescens group as reported by
Redondo-Nieto et al. (2012), with the addition of the genomes
of Pseudomonas corrugata CFBP5454 (ATKI00000000) and P.
mediterranea CFBP5447 (AUPB00000000). Phylogenetic trees
were built by a Composition Vector approach using the web
server CVTree with a k-value of 6 (Xu andHao, 2009). Trees were
generated by the Neighbor joining algorithm with P. aeruginosa
PAO1 as the outgroup. Phylogenetic trees were visualized by
MEGA5.1 (MEGA).
For the identification of secondary metabolite gene clusters
the genome sequence was analyzed by both the on-line analysis
programs NP.searcher (Li et al., 2009) and antiSMASH (Blin
et al., 2013).
Thanapeptin Gene Cluster Analysis
The gene cluster identified to encode a NRPS of 22 amino acids,
was further analyzed for the domains in the synthetases by the
PKS/NRPS predictor (Bachmann and Ravel, 2009). Moreover,
the Adenylation (A)-domains predicted by the PKS/NRPS
predictor were analyzed by a phylogenetic comparison to
known A-domains. MEGA5.1 (MEGA) was used for alignments
and subsequent tree construction, using the neighbor-joining
method and 500 bootstrap replicates. The combination of the
predictions by NP.searcher, antiSMASH, PKS/NRPS predictor
and phylogenetic analysis led to a consensus prediction presented
in Figure 5. The first Condensation (C1)-domain predicted for
the thanapeptin gene cluster was also subjected to phylogenetic
analysis (as described above), with C1-domains of other NRPS
gene clusters, to compare the thanapeptin C1-domain to cyclic
and non-cyclic (lipo)peptides NRPSs (De Bruijn et al., 2007).
In vitro Inhibition Assays
For in vitro growth inhibition of fungi and oomycetes, SH-C52
and its derivative strains were, using an overnight culture in
KB, spot-inoculated (3µl) at the periphery of 1/5th strength
PDA (pH 7.0) plates. After incubation for 2 days at 25◦C, an
agar plug (4-mm-diameter) from a freshly grown plate with
the target organism was transferred to the center of the 1/5th
PDA plate. Inhibition of radial growth of the fungus or the
oomycete was monitored from 2 days after incubation up to 2
weeks after incubation, depending on the growth speed of the
target organism. For in vitro bacteria and yeast inhibition assays,
bacteria and yeast cells were included, after autoclaving and
cooling to 45◦C, into the 1/5th PDA medium at a concentration
of ∼105 cfu/ml. After solidifying and sufficient drying of the
plates, SH-C52 and its derivative strains were, using an overnight
culture in KB, spot-inoculated (3µl) at the periphery of the
bacteria or yeast containing plates.
Activity of Brabantamide A Against Phytophthora
infestans
To test both the brabantamide A antimicrobial effect and the
effect on phospholipase activity of P. infestans, individual P.
infestans mycelial plugs were transferred to a 24-wells plate
(Greiner Bio-One) with each well containing 2ml rye sucrose
broth (Latijnhouwers et al., 2002). Brabantamide A was added to
the broth at the concentrations indicated. Brabantamide A was
dissolved in DMSO, and DMSO concentrations were normalized
for all wells to a final concentration of 1% (v/v). Growth
of P. infestans was monitored for 6–8 days at an incubation
temperature of 18◦C. Mycelial mass was determined after drying
the mycelium for 2 days at 60◦C. Growth experiments were
performed twice, each with two replicates per treatment. As
similar results were obtained, representative results of one
experiment are shown.
To assay the effect of brabantamide A on P. infestans
phospholipid metabolism, mycelial plugs were labeled overnight
with 10 µCi carrier free 32PO3−4 (GE Healthcare, Diegem,
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Belgium). Brabantamide A treatments were performed
simultaneously with the labeling or for 15min after the
labeling. All treatments contained a final concentration of 1%
(v/v) DMSO and 0.1% (v/v) of n-butanol. The latter was well
below phospholipid metabolism stimulatory concentrations
(Latijnhouwers et al., 2002) and was included to detect
transient PLD activity (Munnik et al., 1995; Meijer et al.,
2011). Incubations were halted by addition of perchloric acid
(final concentration 5%) and subsequent freezing in liquid
nitrogen. After thawing 3.75 volume of CHCl3/CH3OH/1M
HCl (50:100:1 by vol) and two glass beads (Ø = 3mm)
were added and the samples were again frozen in liquid
nitrogen. Samples were thawed and thereafter vigorously shaken
for 30min. Samples were further treated and analyzed as
described previously (Latijnhouwers et al., 2002). Radiolabeled
phospholipids separated by TLC were detected and quantified by
phospho-imaging (Storm, Molecular Dynamics; Sunnyvale, CA,
USA).
Mass Spectrometry Analysis
For NanoDESI experiments the instrument setup was according
to Watrous et al. (2012). The nanoDESI source coupled
to a Thermo LTQ-FT-ICR MS capable of collision-induced
dissociation. All analyses were performed in positive ion mode
in the mass range ofm/z from 200 to 2000. Both the primary and
the nanospray capillaries were 150µm o.d. × 50µm i.d., with
solvent being delivered and removed from the liquid bridge at
approximate 45◦ angles. The solvent used was acetonitrile/0.05%
formic acid in water (1:1) running at a flow rate of 0.8–2.5µl/min.
The droplet size using this configuration was ∼200µm in
diameter. MALDI imaging was performed according to Liu
et al. (2010). For both the MALDI imaging and the NanoDESI
experiments, the Pseudomonas sp. SH-C52 and its derivatives
were grown on 1/5th PDA plates.
For antimicrobial assays and detailed MS analysis of the
thanapeptin derivatives, strain Pseudomonas sp. SH-C52 was pre-
grown overnight in 5ml LB at 28◦C. This overnight culture
was used to streak-inoculate (10-µl loop) ISP2 agar plates
[∼12ml/plate, 4 g/l yeast extract (Sigma), 4 g/l dextrose (Sigma),
10 g/l malt extract (Sigma), 7.5 g/l agar (Sigma), 7.5 g/l agar
(Teknova)]. Streak-inoculated plates were grown at 28◦C for
36–44 h. Thanapeptin was extracted by scraping cells from the
plates into solvent (60% acetonitrile/40% water/0.1% formic
acid). Extractions were performed by shaking for 1 h. The cell
extract was transferred to 50-ml centrifuge tubes and cells were
spun down. The extraction was performed on the same cells for
a total of 3 times. The supernatant was dried by rotovap and the
pellet was retrieved by rinsing three times of 6ml of the extraction
solvent. The extraction fluid was collected in a centrifuge tube
and spun down again. Subsequently, the supernatant was dried
by rotovap again using a small 20-ml scintillation vial until
dry. The vial was then rinsed by three washings with 400µl of
extraction solvent and placed in a 1.5ml centrifuge tube and
centrifuged at 14,000 rpm. The supernatant was injected in the
HPLC containing a C18 4.6 × 150mm 5µm analytical column
with a 250µl sample loop. Mobile phase A was 100% water with
0.1% formic acid. Mobile phase B was 100% acetonitrile with
0.1% formic acid. The flow rate was set to 1.0ml/min and a
gradient elution was used with 15% mobile phase B ramped to
95% mobile phase B over 45min. The eluent was collected using
a fraction collector set to collect 1ml fractions. Fractions were
checked for purity and the right mass using MALDI (Bruker).
Purified thanapeptin and its derivatives were subsequently used
in antimicrobial assays, and assayed by MS analysis by a Thermo
LTQ-FT-ICR MS capable of collision-induced dissociation.
Thanapeptin Activities
Compounds were tested in interaction with target organisms
by different techniques. To test activity against bacteria and the
yeast Rhodoturula pilimanae, plates containing the target strain
were used. Bacteria and yeast were added at a concentration
of∼105 cfu/ml to the 1/5th PDAmedium. After sufficient drying
of the plate, filter discs with the test compounds at indicated
concentrations were added to the plate. Plates were incubated
at 25◦C and growth was monitored for 4 days. Activity against
fungal and oomycete strains was tested both in liquid and on
plate. For plate assays, thanapeptin derivatives at a concentration
of 50µM were added directly at the border of a 1/5th PDA, after
which an agar plug (4mm diameter) from a freshly grown plate
with the target fungal or oomycete strain was positioned in the
center of the plate. Hyphal growth was monitored from 2 days
after incubation up to 2 weeks after incubation, dependent on
the growth speed. Testing of compound activity against fungal
and oomycete strains in liquid culture was performed by addition
of the compound to 1ml of liquid 1/5th PDB in a 12 wells
culture plate (Greiner Bio-One), in which an agar plug (4mm
diameter) from a freshly grown plate with the target organism
was submerged. Growth experiments were incubated at 25◦C,
except for P. infestans, which was cultured at 18◦C.
Results
General Genome Features and Phylogeny
Sequencing and assembly showed that the genome size of
Pseudomonas sp. SH-C52 is∼6.3Mbwith a GC content of 61.0%.
The genome was assembled in 596 contigs and 25 scaffolds, with
an estimated coverage of 99.2%. For annotation, 384 contigs of
at least 100-bp and covering 6.3 MB were used. In total, 5579
ORFs were annotated with 5523 CDSs and 56 tRNAs (Table 1).
Previous analysis of the 16S rRNA sequence placed SH-C52
within the P. fluorescens clade (Mendes et al., 2011). At that
time, however, no conclusive species designation was obtained.
Expanding the former genome-wide phylogenetic analysis on
P. fluorescens species (Redondo-Nieto et al., 2012) with the
SH-C52 genome and the recent draft genomes of P. corrugata
CFBP5454 and P. mediteranea CFBP5447, showed that strain
SH-C52 clusters within subgroup I of the P. fluorescens group.
Within subgroup I, SH-C52 and the strains of P. corrugata and
P. mediterranea form a separate clade (Figure 1).
In silico Analysis of Pseudomonas sp. SH-C52
Primary Metabolism
The metabolic potential of Pseudomonas sp. SH-C52 was
analyzed by comparing genes from primary metabolism with
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TABLE 1 | General genome sequence information of Pseudomonas sp.
SH-C52.
Scaffold Contig > 100bp
Number 25 384
Total Length (bp) 6,356,481 63,12,590
Max length (bp) 1,572,034 292,658
Min length (bp) 505 102
Sequence GC(%) 61.0 61.0
Gene number 5808 5579
tRNAs 55 56
FIGURE 1 | Whole genome phylogenetic analysis of Pseudomonas sp.
SH-C52. Phylogenetic tree constructed by use of CVtree, and based on the
analysis performed previously by Redondo-Nieto et al. (2012), with the addition
of strains SH-C52, P. corrugata CFBP5454 and P. mediterranea CFBP5447.
those known for the P. fluorescens clade (Loper et al., 2012). In
this analysis, also its close relative P. corrugata strain CFBP5454
was included as well as P. mandelii strain JR-1 as a representative
strain for subgroup III. The comparative analysis showed that for
several of the metabolic activities in species of the P. fluorescens
clade, the gene sequences are also found in strain SH-C52.
These include genes involved in catabolism of L-arabinose,
mannitol, myo-inositol, and ethanol, as well as genes coding for
gelatinase and lipase. The ethanol catabolism genes, however,
were only detected in five of the 12 other studied strains of
the P. fluorescens clade, including subgroup I strains Q8r1-96,
Q2-87, and P. corrugata CFBP5454. In contrast, genes encoding
catabolic pathways for trehalose (10 strains), levan sucrase (7
strains) and L-tryptophan (7 strains, only subgroup IV and V)
are present in multiple strains of the P. fluorescens clade, but
were not detected in the SH-C52 genome (Table 2). Interestingly,
comparing the SH-C52 genes with genes in the genome of
P. corrugata CFBP5454 showed a few remarkable differences.
Genes for trehalose catabolism were found in P. corrugata but
not in SH-C52. The same was found for the nitrate reductase
gene cluster previously reported for P. corrugata strains (Siverio
et al., 1993). These differences in the presence of genes involved
in primary metabolism further strengthen the phylogenetic
delineation (Figure 1) where SH-C52 is closely related to, but
different from P. corrugata.
Genome Analysis of Traits Involved in
Plant-microbe Interactions
In silico analysis of the SH-C52 genome for genes involved in
the production of phytohormones, volatiles, and plant signaling
compounds led to the identification of putative pathways for
acetoin/butanediol and for GABA catabolism (Table 3). Also the
different bacterial secretion systems are of crucial importance for
plant-microbe interactions (Korotkov et al., 2012; Russell et al.,
2014; Tampakaki, 2014). The genome of SH-C52 contains two
gene clusters encoding type II secretion systems with significant
sequence similarity (>70%) to the Xcp and Hxc systems of
P. aeruginosa (Table 3). Genes encoding potential substrates of
the type II secretion system, such as lipases, proteases, esterases
and alkaline phosphatases (Douzi et al., 2012) are well presented
in the SH-C52 genome (Tables 2, 3). No genes encoding a type
III secretion system were found in the SH-C52 genome, yet two
putative effector genes for this secretion system were identified
(BN844_1916 and BN844_3678). Type VI secretion systems are
conserved among Gram-negative bacteria and are thought to be
involved in bacteria-bacteria interactions (Russell et al., 2014).
Two gene clusters were found to encode type VI secretion
systems of which one (BN844_4205-4227) was typed as a HSI-
I locus and the second (BN844_0760-0774) as a HSI-III locus
(Table 3).
Genome Analysis for Secondary Metabolites
To predict putative secondary metabolites, such as antibiotics,
siderophores and other NRPS genes, the genome sequence
was first screened by BLAST for ORFs of known compounds
produced by other species and strains of the P. fluorescens clade
(Loper et al., 2012). Only five SH-C52 clusters corresponded
with known clusters (Table 3). First of all, the gene cluster
for hydrogen cyanide production (HCN, BN844_0823-0821)
was found in the SH-C52 genome and corresponded to the
gene cluster found in eight out of the 10 previously sequenced
Pseudomonas species (Loper et al., 2012). No pyoverdine
synthetase gene cluster was found in SH-C52, which was also
the case for P. corrugata. This corresponds to the observation
that P. corrugata strains are known to be pyoverdine negative
(Meyer et al., 2002). The siderophore gene cluster identified
for SH-C52 is achromobactin (BN844_0513-0523). This gene
cluster is not common among members of the P. fluorescens
species clade, but has been described for P. syringae strains
(Berti and Thomas, 2009; Owen and Ackerley, 2011) and for two
P. chlororaphis strains (Loper et al., 2012), and is also found in the
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TABLE 2 | Primary metabolism and corresponding genes of Pseudomonas SH-C52.
Function I II III IV V
SH-C52 Pc 5454 Q8r1-96 Q2-87 Pf0–1 Pm JR-1 Pf-5 30–84 O6 SBW25 A506 SS101 BG33R
Gelatinase BN844_0247
Lipase BN844_0271
Phenylacetic acid
Sodium Benzoate
Trehalose
Levan sucrase
L-arabinose BN844_3151-3149
Nitrate reduction
D-serine
Denitrification
Ethanol BN844_0564
Sorbitol
Mannitol BN844_0168
myo-Inositol BN844_0814
D-xylose BN844_0249
L-tryptophan
*Functions are based on the 10 strains studied by Loper et al. (2012). The roman numbers are indicating subgroups within the P. fluorescens clade as identified by Redondo-Nieto et al.
(2012), for which also the gray shades are indicative. Strains studied by Loper et al. (2012) are also included in the table, with the addition of P. corrugata CFBP5454 (Pc 5454) and P.
mandelii JR-1 (Subgroup III). For SH-C52 the locus tags for the corresponding genes are given.
genome of P. corrugata strain CFBP5454 (WP_024777665-670,
Table 3). In addition to the achromobactin gene cluster, an NRPS
gene cluster (BN844_2194-2167) was identified with similarity
to genes presumably involved in ornicorrugatin biosynthesis.
The putative (orni)corrugatin gene cluster identified in SH-
C52 was also found in P. fluorescens strains Q8r1-96 and
SBW25. Ornicorrugatin and the related compound corrugatin
are so-called secondary siderophores (Matthijs et al., 2008). For
P. fluorescens, however, conclusive experiments that link the
production of (orni-) corrugatin to its putative gene cluster are
still lacking.
Two other gene clusters in SH-C52 were predicted to encode
insecticidal toxins. The first gene cluster is related to the Tcc2
toxin for which the genes are also found in the genomes of
P. fluorescens strains Q8r1-96 and Q2-87. The second insect
toxin gene cluster is similar to that of Tcc4 toxin (Table 3).
No bacteriocin gene clusters could be identified with similarity
to those found in other genomes of the P. fluorescens clade.
However, a prophage gene cluster (BN844_3382-3419) flanked
by cinA and mutS, typical for prophages present in other
Pseudomonas genomes (Loper et al., 2012), was identified in the
genome of SH-C52.
Non-ribosomal Peptide Synthetases
The SH-C52 genome contains six NRPS gene clusters, including
the putative (orni-) corrugatin gene cluster (Figure 2). The
other five clusters include the known NRPS gene clusters
for the synthesis of thanamycin (BN844_0670-0673 and
BN844_0703-0704, Mendes et al., 2011), and brabantamide
(BN844_0705-0707, Schmidt et al., 2014). In close proximity
to the thanamycin and brabantamide gene clusters, a third
NRPS gene cluster (BN844_0667-0664) was identified
(Figure 2). This NRPS is predicted to code for a 22 amino-
acid lipopeptide with similarity to corpeptin (Figure 2) produced
by P. corrugata. Therefore, in agreement with the naming
of cormycin and corpeptin, we designated the predicted 22-
amino-acid compound of SH-C52 as thanapeptin. The genome
of P. corrugata CFBP5454 contains several NRPS genes with
similarity to the 22 amino-acid related gene cluster in SH-C52.
However, in P. corrugata this gene cluster is divided over different
contigs. Recently, a partial gene cluster containing a partial NRPS
gene, encoding two adenylation-domains and two transport
genes, were linked to corpeptin production (Strano et al., 2014).
Because of the incomplete nature of the draft genome sequence
for strain CFBP5454, it remains unclear if the organization of
the gene clusters for cormycin and corpeptin of P. corrugata is
also similar to that of thanamycin and thanapeptin in SH-C52.
However, consistent with the gene organization in SH-C52,
a putative brabantamide-like gene cluster was also found in
P. corrugata down-stream of the putative cormycin gene cluster
(Figure 2). In addition, the biocontrol strain P. fluorescens
In5 was recently reported to produce the antagonistic
metabolites nunamycin and nunapeptin, also with similarity to
cormycin and corpeptin, respectively. Although gene clusters
for nunamycin and nunapeptin were presented (Michelsen
et al., 2015), the genome information of strain In5 was not
provided.
The fourth NRPS gene cluster (BN844_0379-0382) found in
SH-C52 is predicted to code for an NRPS that produces an 8-
amino-acid lipopeptide, with no significant similarity to other
known compounds in general and dedicated databases such
as NCBI and the Norine peptide database. This gene cluster
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TABLE 3 | Secondary metabolite production and corresponding genes of Pseudomonas sp. SH-C52.
I II III IV V
SH-C52 Pc 5454 Q8r1-96 Q2-87 Pf0-1 Pm JR-1 Pf-5 30-84 O6 SBW25 A506 SS101 BG33R
ANTIBIOTICS
DAPG
HCN BN844_0823-0821
Phenazine
Pyrrolnitrin
Rhizoxin
Pyoluteorin
HPR
NRPS/SIDEROPHORE/TOXINS
CLP* Figure 2
Siderophore Pyoverdine
Pyochelin
Pseudomonine
Achromobactin BN844_0513-0523
Hemophore
NRPS1—MgoA BN844_4882
NRPS3 BN844_2194-2167#
Bacteriocin BN844_3382-3419
Insect toxins FitD toxin
Tcc1
Tcc2 BN844_3853-3849 2
Tcc3
Tcc4 BN844_2985-2986
Tcc5
EXOENZYMES
Chitinase 1*
Chitinase 2
AprA BN844_0247
AprX
Protease 1
Protease 2
Protease 3
Protease 4
Pectate lyase
SECRETION SYSTEMS
Type II T2SS Xcp* BN844_4825-4833
T2SS Hxc
T2SS Hxc-2 BN844_2047-2057
T2SS novel
Type III T3SS 1
T3SS 2
T3SS 3
T3SS effectors ExoU
RopB
RopM
RopAA-1
Novel Effector
Putative Effectors BN844_1916,
_3678
(Continued)
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TABLE 3 | Continued
I II III IV V
SH-C52 Pc 5454 Q8r1-96 Q2-87 Pf0-1 Pm JR-1 Pf-5 30-84 O6 SBW25 A506 SS101 BG33R
Type VI HSI-I BN844_4205-4227
HSI-II
HSI-III BN844_0760-0774
TSS4
PLANT COMMUNICATION
IAA biosynthesis
IAA catabolism
PAA catabolism
ACC deaminase
Butanediol synthesis
Acetoin/Butanediol* BN844_0610-0604
Acetoin catabolism
GABA catabolism BN844_4573-4574
*Functions are based on the 10 strains studied by Loper et al. (2012). The roman numbers are indicating subgroups within the P. fluorescens clade as identified by Redondo-Nieto et al.
(2012), for which also the gray colors are indicative. Strains studied by Loper et al. (2012) are also included in the table, with the addition of P. corrugata CFBP5454 (Pc 5454) and P.
mandelii JR-1 (Subgroup III). For SH-C52, the locus tags for the corresponding genes are given. Cyclic lipopeptides (CLP) for SH-C52 are discussed in the text and listed in Figure 2.
#The SH-C52 NRPS3-corrugatin gene cluster sequence is incomplete and divided over different contigs.
appears to be unique for SH-C52, as it was not found in other
genomes. The last NRPS gene cluster identified in SH-C52
shows similarity to mgoA-like gene clusters, encoding only one
adenylation domain. MgoA or MgoA-regulated compound(s)
were proposed to regulate the expression of pathogenicity factors
in P. entomophila and P. syringae (Vallet-Gely et al., 2010; Carrion
et al., 2014), although the underlying mechanism is yet unknown.
Thanamycin: Gene Cluster and Antimicrobial
Activity
Based on mutant analysis, the thanamycin gene cluster was
shown to be important for the growth-inhibitory activity of
strain SH-C52 against Rhizoctonia solani (Mendes et al., 2011).
The thanamycin gene cluster shows similarity to a fragmented
NRPS gene cluster in P. corrugata CFBP5454 (Figure 2), but the
incomplete and scattered P. corrugata sequences complicate a
clear comparison between the thanamycin and cormycin gene
clusters. Alignments of the thanamycin NRPSs and the annotated
parts of cormycin NRPSs show 85–97% protein identity. To
test the antimicrobial activity-spectrum of thanamycin, wild type
SH-C52 and two thanamycin biosynthesis mutants (Mendes
et al., 2011) were tested for activity against fungi, oomycetes and
bacteria. Here, we show that the activity spectrum of thanamycin
is not exclusive for R. solani, but extends to an array of other fungi
(Figure 3) and the Gram-positive bacterium Bacillus megaterium
(data not shown). Also cormycin has been shown to be active
against B. megaterium and the yeast Rhodotorula pilimanae
(Scaloni et al., 2004). In contrast, thanamycin has little activity
against oomycete pathogens (Figure 3) and the Gram-negative
bacteria Pseudomonas syringae and Pectobacterium atrosepticum
(data not shown).
Brabantamide: Gene Cluster and Antimicrobial
Activity
The gene cluster and the brabantamide compounds
were previously identified (Schmidt et al., 2014).
Interestingly, a putative brabantamide gene cluster is
also present in the genome of P. corrugata (Figure 2)
as well as in the genome of P. fluorescens DSM 11579
(Johnston et al., 2013).
In previous studies, brabantamides were shown to have
activity against specific Gram-positive bacteria (Reder-Christ
et al., 2012; Schmidt et al., 2014). Here, we show that
brabantamide A, at a concentration of 50µM, has activity against
the oomycete plant pathogens Phytophthora capsici, Pythium
ultimum, and P. infestans (Figure 4). No antifungal activity was
observed at this concentration (data not shown). For P. infestans,
mycelial growth was already inhibited at concentrations above
5µM resulting in a less dense mycelial mat (Figure 4A). Previous
studies suggested that structural analogs of brabantamide A
inhibit phospholipase A2 of rabbit (Thirkettle et al., 2000). When
[32P]Pi-labeled hyphae of P. infestans were incubated for 15min
with brabantamide, no significant variation in the phospholipid
levels was observed (data not shown). However, overnight
exposure of P. infestans mycelium to brabantamide A led to
an increase in the phosphatidylbutanol (PtdBut) levels. This
already occurred at a concentration of 1µM brabantamide A,
the lowest concentration tested (Figure 4). Other phospholipid
levels were not affected based on quantification. The enhanced
PtdBut levels indicates a stimulatory effect of brabantamide
A on phospholipase D activity. In contrast, no indication
was found for the inhibition of phospholipase A2 in this
assay.
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FIGURE 2 | Non-ribosomal peptide synthetase gene clusters
present in the genome of Pseudomonas sp. SH-C52. (A) The six
NRPS gene clusters predicted in the genome of SH-C52. (B) A
comparison of the SH-C52 thanamycin-thanapeptin-brabantamide cluster
with the putative equivalent cluster of P. corrugata CFBP5454.
Thana/corpeptin related NRPS genes are in dark gray, thana/cormycin
NRPS genes are in light gray, and brabantamide genes are in near
black. The P. corrugata genes are not bordered, as the genome
information is scattered over contigs and needs to be confirmed. Dotted
lines indicate (expected) sequence conservation. Amino acids are
indicated in their standard three-letter annotation. Non-standard amino
acids were abbreviated as follows: Hse, homoserine; Ilx, isoleucine or
leucine; Dab, 2,4-diaminobutanoic acid; Dhb, 2,3-dehydro-
2-aminobutanoic acid; Dhp, dehydro-2-aminopropanoic acid
(dehydroalanine). The asterisk in the thana/cormycin structure indicates
chlorination of this amino acid.
FIGURE 3 | Antagonistic activity of Pseudomonas sp. SH-C52.Wild-type
(WT) and the thanamycin mutant strains (ThaB, ThaC2) were tested in dual
culture assays for activity against fungal plant pathogens (upper panel) and
oomycete plant pathogens (lower panel).
Thanapeptin: Gene Cluster, Structural Analysis
and Antimicrobial Activity
The thanapeptin gene cluster consists of three NRPS genes.
BLAST analysis of the protein sequences showed similarity
with the NRPSs for the production of the LP syringopeptin
of P. syringae. Indeed, the first gene of the thanapeptin
cluster starts with a specific condensation (C)-domain, a so-
called C1 starter domain (data not shown), suggesting N-
acylation of the first amino acid in the peptide moiety. The
three NRPS genes of the thanapeptin gene cluster encode
nine, four and nine adenylation (A)-domains, respectively. The
prediction of the 22 amino acids activated by these A-domains
is shown in Figure 5. The C-terminus of the last gene of
the cluster encodes two thioesterase (TE)-domains, indicating
termination of the thanapeptin synthesis. Despite the similarity
between syringopeptin and thanapeptin (Figure 2), there also
is a clear difference in modular organization as syringopeptin
is produced from three NRPS modules, with five, five and
twelve adenylation domains, respectively. Comparison with the
P. corrugata CFBP5454 draft genome sequence shows that the
corpeptin gene cluster sequence is incomplete and scattered over
contigs. Nevertheless, for the annotated parts, protein identities
with the SH-C52 NRPSs ThpA and ThpC ranged between 75 and
95%, whereas for ThpB identities ranged between 60 and 80%.
Using MALDI and live colony NanoDESI mass spectrometry,
a specific group of ions was detected for which the parent
mass ranged from 2082 to 2150 Da. Comparing the tandem MS
spectra of this set of ions indicated these are related peptides,
probably produced by the same NRPS gene cluster. Usage of the
peptidogenomics approach (Kersten et al., 2011) on the tandem
MS data of these ions (Supplementary Data) revealed that they
can be linked to the predicted thanapeptin peptide sequence, and
thus to the thanapeptin NRPS gene cluster. MS analysis of the
extracts from the thanapeptin mutants indeed showed that the
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FIGURE 4 | Antimicrobial and phospholipase D stimulating activity
of brabantamide A in interaction with Phytophthora infestans.
(A) Growth of P. infestans in liquid medium with different
concentrations of brabantamide A. (B) Dry weight of P. infestans
grown in liquid medium (n = 2). (C) Lipids extracted from P. infestans,
separated by alkaline (left) or ethylactetate (EtAc) TLC (right) and
analyzed by phosphoimaging. The origin of the chromatogram,
phosphatidylinositolphosphate (PtdInsP), phosphatidic acid (PtdOH),
phosphatidylinositol (PtdIns), phosphatidylcholine (PtdCho),
phosphatidylethanolamine (PtdEtn), phosphatidylglycerol (PtdGro) and
phosphatidylbutanol (PtdBut) are indicated. (D) PtdOH and PtdBut
were quantified from the EtAc TLC and presented as the fold increase
when compared to control conditions (n = 2). Error bars represent
standard deviations.
production of all ions of the putative thanapeptin group were
absent (data not shown). Further analysis of the tandemMS data
of the subsequently purified ion of 2120 Da was in agreement
with the in silico predicted amino acid sequence for thanapeptin.
In addition, tandem MS data provided evidence for cyclization,
and resolved the identity of the lipid moiety of thanapeptin
(Figure 5 and Supplementary Presentation 1).
The role of the thanapeptin gene cluster in the activity
of SH-C52 against fungi, oomycetes and bacteria was studied
by comparing wild-type strain SH-C52 and two independent
mutants, each with a single transposon insertion in the
thanapeptin NRPS gene cluster. The two mutants lost their
antagonistic activity against oomycete pathogens, whereas they
still had activity against fungi (Figure 6) and bacteria (data
not shown). From the wild-type strain, thanapeptin derivatives
were purified and seven derivatives were tested for activity
against the oomycete P. infestans. Substantial differences in
anti-oomycete activity were observed between the compound
derivatives, with the strongest activity for those with the lowest
mass, i.e., compounds with the masses 2082, 2096, 2108, and
2122 Da (Figure 7A). In addition, two derivatives with strong
activity, 2096 and 2122 Da, were also tested against the oomycete
pathogens Saprolegnia parasitica and P. ultimum. Similar results
were obtained as in the assays with P. infestans, with the strongest
activity for the derivative with a mass of 2096 Da, and slightly
lower activity for the derivative with a mass of 2122 Da (data
not shown). Subsequently, the activity of the derivative with a
mass of 2096 Da was tested at different concentrations against
the three oomycete pathogens in a liquid broth. For P. infestans
(Figure 7), a clear reduction in mycelial growth was observed at a
concentration of 0.25µg/ml. For syringopeptin or corpeptin, no
anti-oomycete activity has been reported to date (Vassilev et al.,
1996; Emanuele et al., 1998). No apparent antifungal activity
or activity against Gram-negative bacteria was observed for any
of the thanapeptin derivatives, whereas activity was observed
against the Gram-positive bacterium B. megaterium (data not
shown), which is in line with results observed previously for
syringopeptin and corpeptin (Vassilev et al., 1996; Emanuele
et al., 1998).
Discussion
Pseudomonas sp. SH-C52 was initially studied for its role in the
natural soil suppressiveness against the fungal pathogen R. solani
(Mendes et al., 2011). Here we show by both genome and
metabolomic analyses that this plant-associated bacterium has a
much greater genomic capacity for the production of secondary
metabolites. We showed that Pseudomonas sp. SH-C52 can be
placed within subgroup I of P. fluorescens species (Redondo-
Nieto et al., 2012) as a separate clade together with P. corrugata
and P mediterranea. P. corrugata strains have been reported for
biological control, for bioremediation and for the production of
a range of biomolecules. In contrast, P. corrugata strains have
also been reported as plant pathogenic bacteria (Catara, 2007).
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FIGURE 5 | Thanapeptin genetic and chemical analysis. (A) The upper
panel shows the interaction of SH-C52 in interaction with R. solani, as
imaged by MALDI imaging mass spectrometry (IMS). Thanamycin and
thanapeptin detection by MALDI IMS are shown. (B) The middle panel
presents the thanapeptin gene cluster with the position of the transposon
insertions, and the modules encoded by the gene clusters and the prediction
for the amino acids assembled. On the middle left, the partial spectrometry
profile of the MALDI IMS of the SH-C52 and R. solani interaction is shown.
(C) At the bottom the tentative thanapeptin structure obtained from tandem
mass spectrometry data is presented. Dashed arrows indicate amino acids
that are difficult to predict from genome information, and that needed to be
resolved by mass spectrometry.
Indeed, the sequenced strain P. corrugata CFBP5454 was isolated
because of its pathogenic properties (Licciardello et al., 2007).
In contrast, Pseudomonas sp. SH-C52 was isolated because of
its plant-beneficial and antagonistic properties (Mendes et al.,
2011). For P. corrugata, regulation of cormycin and corpeptin
production is under the control of anN-acyl-homoserine-lactone
quorum sensing system (Licciardello et al., 2012), for which the
genes are conserved in strain SH-C52 (data not shown). For
both, the quorum sensing system is located down-stream of
the thana/corpeptin gene clusters. The different origin of these
strains suggests that structurally identical secondary metabolites
can have diverse functions, depending on the niche where they
are produced. For instance they can fight off pathogen threats for
certain plant niches, as is the case for thanamycin in protecting
sugar beet seedlings, or are advantageous to occupy certain
niches, as is the case for cormycin during infection of plants.
In addition to thanamycin and thanapeptin, Pseudomonas
sp. SH-C52 produces a third LP with antimicrobial activity.
Previously, brabantamides were shown to be active against
specific Gram-positive bacteria (Reder-Christ et al., 2012;
Schmidt et al., 2014). Here we report that brabantamide A
also has activity against oomycetes. Interestingly, this compound
has received considerable attention for the development of the
synthetic phospholipase inhibitor darapladib, which is tested
for treatment of atherosclerosis (Johnston et al., 2013). This
highlights the importance of identifying novel LPs for the
development of new medicines. In this respect it is interesting to
note that in the genome of Pseudomonas sp. SH-C52 a putative
fourth LP-NRPS gene cluster is present, with a yet unknown
structure and function. Also an mgoA-like NRPS gene was
identified in the genome of SH-C52. Although the mgo-operon
was shown to be essential for mangotoxin production in mango-
pathogenic P. syringae strains (Arrebola et al., 2012), it was later
demonstrated that the biosynthesis of mangotoxin occurs by
means of the mbo-operon (Carrion et al., 2012). This suggests
that MgoA likely has a regulatory function (Carrion et al., 2014).
An orthologous gene cluster was shown to be essential for insect
pathogenicity in P. entomophila, however, no pathogenicity
factor or compound has yet been linked to this phenotype (Vallet-
Gely et al., 2010). The mgo-operons are not only present in
pathogenic bacteria, but are widespread among Pseudomonas
species, including species from the P. fluorescens clade (Loper
et al., 2012). Since the product from MgoA, or the mgo-
operon, has not been deduced, the function of the mgo-operon
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FIGURE 6 | Antagonistic activity of Pseudomonas sp. SH-C52. The
wild-type (WT) and the thanapeptin mutants strains, Tn-tnpA (TnpA) and
Tn-tnpC (TnpC) were tested in dual culture assays for activity against fungal
plant pathogens (upper panel) and oomycete plant pathogens (lower panel).
FIGURE 7 | Activity of thanapeptin derivatives against Phytophthora
infestans. (A) Activity of thanapeptin tested on plate. Numbers indicated in
the pictures are the parent mass of the derivate tested in Da. (B) For the
derivate of 2096 Da the growth-inhibitory activity was tested in liquid broth, at
different concentrations, indicated in the picture in µg/ml.
remains an intriguing question. The Mgo-product may act
as a Pseudomonas specific switch for secondary metabolite
production or as a genus- or species-specific regulator involved
in different functions.
The production of secondary metabolites often comes at the
expense of primary metabolism (Ruiz et al., 2010). Therefore,
production needs to be tightly regulated in a temporal and
spatial manner. Pseudomonas sp. SH-C52 has the ability to
produce at least three and likely four structurally different LPs,
each with structural variants. LPs have diverse natural functions
in motility, biofilm formation, antibiosis, defense or virulence
(Raaijmakers and Mazzola, 2012). These functions have to be
strictly regulated and cannot be performed all at once. Some
LPs are produced at the same time but may have different
roles. This is the case for two LPs produced by Pseudomonas
CMR12a, i.e., sessilin and orfamide that are produced together
but involved in respectively biofilm formation and swarming.
Regulation takes place by the fact that sessilin hampers the release
of orfamide by co-precipitating with orfamide (D’Aes et al.,
2014). Although we do see that thanamycin and thanapeptin can
be produced simultaneously by Pseudomonas SH-C52 (Figure 5),
we do not see the simultaneous production of the other
two LPs. This suggests dissimilar regulatory pathways for the
production of these LPs, possibly with negative and positive
feedback loops. Three of the LPs produced by SH-C52 have
antimicrobial activity in vitro, but it remains to be studied if
these LPs also have antimicrobial activity in vivo. In this respect,
future studies will focus on the identification of regulatory
pathways and identification of specific extracellular cues that
trigger the production of the structurally diverse LPs in SH-
C52 in interactions with diverse organisms encountered in the
rhizosphere environment.
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